Clinical Trial Update: Natural Killer-cell Therapy for Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial evaluating natural killer cell therapy for adult acute myeloid leukemia (refractory or relapsed) in Phase 1/2 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Natural Killer cell therapy (natural killer cell therapy)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult | Phase 1, Phase 2 | Status: TERMINATED